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journal homepage: www.j fma-onl ine.comLETTER TO THE EDITORAntimicrobial drug-resistant microbes have a
higher risk of health care-associated
pneumonia in eastern TaiwanTo the Editor,
A previous report reminds us of the risks of antimicrobial
drug-resistant microbes in hospitalized patients with
community-acquired or health care-associated pneu-
monia.1 The report included six medical centers in the
northern, central, and southern parts of Taiwan. However,
infection by increasingly drug-resistant microbes also poses
a great risk in the eastern part of Taiwan. In 2013, health
care-associated pneumonia accounted for 8.2% (63/773) of
health care-associated infections in 47.6% (30/63) of med-
ical departments and 52.4% (33/63) of surgical departments
in one medical center in eastern Taiwan. The common
isolated pathogens were Staphylococcus aureus, Acineto-
bacter baumannii, Pseudomonas aeruginosa, and Klebsiella
pneumoniae. The drug resistance rates were 62.6% for
oxacillin resistance, 52.7% for carbapenem resistance,
15.3% for multiple drug resistance, and 5.3% for resistance
to extended-spectrum b-lactamases. Carbapenem-resistant
Acinetobacter baumannii infection has a higher risk of
medical complications and mortality.2 Antimicrobial con-
sumption significantly increases the risk of developing drug-
resistant microbes.3 In private clinics and hospitals, it is
important to use antimicrobials by the appropriate type,
dose, and duration.
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